Covid 19 Update
All Stories for Covid 19 Update
India logs 2,338 new COVID-19 cases in last 24 hours, down 13.59% from yesterday
Fp Staff •There has been an increase of 185 in the active COVID-19 caseload in the last 24 hours. The country now has 17,883 active cases of coronavirus
India's active COVID-19 cases rise to 15,814 as country logs 2,710 new infections in 24 hrs
•Meanwhile, the coronavirus death toll climbed to 5,24,539 with 14 fresh fatalities, the data updated at 8 am stated
India logs 2,226 new COVID-19 infections; active cases dip to 14,955
•The active cases comprise 0.03 per cent of the total infections, while the national COVID-19 recovery rate was recorded at 98.75 per cent, the ministry said.
COVID-19 update: India reports 1,109 new cases, 7.35% higher from a day ago
Fp Staff •The cumulative tally of COVID-19 cases in India has now risen to 4,30,33,067. The daily COVID-19 positivity rate of the country reported on Friday was at 0.24 per cent, up from 0.21 per cent a day ago
COVID-19 update: India reports 1,086 new cases, up 36.60% from yesterday; positivity rate rises to 0.23%
Fp Staff •The new cases of COVID-19 reported on Wednesday are 36.60 per cent higher than 795 fresh infections reported on Tuesday
India logs 1,270 fresh COVID-19 cases, recovery rate jumps to 98.75%
•The daily positivity rate was recorded at 0.29 per cent while the weekly positivity rate was 0.26 per cent, according to the health ministry.
India records 1,421 fresh COVID-19 cases, recovery rate jumps to 98.75%
•The last 24 hours saw a total of 6,20,251 COVID-19 tests being conducted. India has so far conducted over 78.69 crore cumulative tests
Shanghai warns against 'panic' as COVID-19 cases mount in China
•Shanghai authorities have called for calm as worried citizens swamped online grocery platforms to stock up on food over fears of impending lockdowns
Why manufacturing licence of Remdesivir was not given to pharmaceutical PSUs, asks Parliamentary panel
Himanichandna •Since Remdesivir has been included in the National Treatment Protocol as an optional drug in curing critical coronavirus patients, the committee recommended that the Centre conduct scientific studies to check the efficacy of the drug and asked it to explore possibilities to manufacture COVID essential drugs by PSUs under it
COVID vaccination pace slowed down in India as most target beneficiaries covered, says Centre
•States and UTs have been advised to review programme coverage and vaccine wastage on a daily basis and redistribute the vaccine stock for their optimal utilisation